Clinical Research Directory
Browse clinical research sites, groups, and studies.
Semaglutide Health Outcomes and Patient Adherence in Australia
Sponsor: Novo Nordisk A/S
Summary
This observational study aims to generate real-world evidence on the use of semaglutide in adults with overweight or obesity receiving care through a digital weight loss service (DWLS) programme in Australia. The study will evaluate treatment patterns, adherence, quality of life, safety, and other health outcomes associated with semaglutide use in routine clinical practice. Information will be collected from data generated during standard clinical care, and no study-specific treatment or procedures will be required.
Official title: Semaglutide Health Outcomes and Patient Adherence on Digital Health Platforms in Australia (SHAPED-AU)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10000
Start Date
2026-10-13
Completion Date
2028-02-28
Last Updated
2026-10-19
Healthy Volunteers
No
Conditions
Interventions
Semaglutide
All decisions regarding treatment will be made at the sole discretion of the treating HCP in accordance with their usual practices. No study medication will be provided as part of the study.
Locations (1)
Novo Nordisk Investigational site
Sydney, Australia